BioSpace News Archive

Genetown

Arrakis Therapeutics Announces Release of SHAPEware Bioinformatics Tools as Open-Source Software

Arrakis Therapeutics announced that it has released SHAPEware as open-source software for the research community with the goal of promoting and facilitating the use of SHAPE-based approaches to study RNA structure.

October 25, 2017

·

4 min read

Genetown

ImmusanT Announces Acceptance of Late Breaking Celiac Interleukin Data at United European Gastroenterology (UEG) Week

ImmusanT today announced data from a study evaluating cytokine levels following gluten ingestion in celiac disease (CeD) and non-celiac gluten sensitive (NCGS) patients has been accepted as a “late breaker” at United European Gastroenterology (UEG) Week.

October 25, 2017

·

4 min read

J&J Scoops Up German Surgery Software Maker for Un

Drug Development

Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA Meets Goals in Phase III Study

The once-daily single tablet complete regimen demonstrates effective viral suppression in HIV-1 patients.

October 25, 2017

·

9 min read

Biotech Bay

SyncThink Mobilizes Eye-Tracking VR Assessment Using Couchbase for Quicker Access to Brain Health Data

Couchbas announced that SyncThink, a world leader in neuro-technology, has adopted Couchbase to provide secure, HIPAA-compliant, offline capabilities for its EYE-SYNC solution.

October 25, 2017

·

5 min read

Business

Novoheart Strengthens North American Presence Opening New R&D Location at the World-class Cove Facility, UC Irvine, California

Novoheart, a global stem cell biotechnology company, is pleased to announce that it has opened a new US location in The Cove at UC Irvine, California.

October 25, 2017

·

5 min read

Biotech Bay

First Patients in U.S. Treated With Varian HyperArc High Definition Radiotherapy

Varian today announced five patients with brain cancer became the first patients in the US to be treated using the company’s HyperArc High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment, at the University of Alabama at Birmingham Comprehensive Cancer Center.

October 25, 2017

·

2 min read

New DePuy Synthes Spine Technologies Help Simplify Minimally Invasive Surgery by Enhancing Efficiency and Reducing Steps

DePuy Synthes today is launching two solutions for minimally invasive spinal fusion surgery designed to simplify the procedure, particularly as MIS gains traction and shows reduced complications compared to open surgery in treating degenerative disc disease in the back.1,2

October 25, 2017

·

4 min read

GS Medical USA Announces New Product Portfolio of Spinal Solutions

Today, GSM announced the full launch of the AnyPlus Direct Lateral Interbody Fusion System after three months of an alpha launch period, and the Anterior and Posterior Disc Prep Sets.

October 25, 2017

·

2 min read

Genetown

Updated Clinical Data From Combination of X4P-001-IO and Inlyta (Axitinib) in Patients With Clear Cell Renal Cell Carcinoma Will Be Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

X4 Pharmaceuticals today announced that the American Association for Cancer Research (AACR) has published Phase 1 data from an ongoing Phase 1/2 study of X4P-001-IO in combination with Inlyta® (axitinib), Pfizer’s VEGFR kinase inhibitor.

October 25, 2017

·

3 min read

Business

Praxair Signs New Long-Term Contract With BASF in the U.S. Gulf Coast

Praxair, Inc., a leading global industrial gas company, and BASF signed a long-term agreement for Praxair to design, build, own, and operate a new syngas processing plant at BASF’s facility in Geismar, Louisiana.

October 25, 2017

·

2 min read